tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 95.0%, 500g

(R)-2-((tert-Butoxycarbonyl)amino)-3-cyclopentylpropanoic acid, 95.0%, 1g

alpha-(Dimethylamino)phenylacetonitrile, 97%, 5g

1-(Boc-amino)-3,6-dioxa-8-octaneazide, 98.0%, 250mg

1-[2-(chloromethyl)phenyl]-1H-pyrazole hydrochloride, 95.0%, 5g

tert-butyl 4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}piperidine-1-carboxylate, 97.0%, 250mg

(Z)-2-(3-oxo-2-(pent-2-en-1-yl)cyclopentyl)acetic acid, 85%, 250mg

5H-Pyrrolo[3,4-b]pyridin-7(6H)-one, 95.0%, 250mg

Volumetric flasks class A transparent, 500 ml, 19/26, 2 Piece(s)

3-AMINOQUINOLINE-5-CARBOXYLIC ACID, 95.0%, 250mg

2',5'-Bis(decyloxy)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde, 97%, 250mg

6,7-DIFLUOROQUINAZOLIN-4(3H)-ONE, 95.0%, 1g

Methyl 6-amino-1H-indazole-7-carboxylate, 95.0%, 5g